PeproTech |
250-23(A) |
Recombinant murine MDC (CCL22)
|
5ug |
|
|
PeproTech |
300-57(A) |
Recombinant human MEC (CCL28)
|
5ug |
|
|
PeproTech |
250-30(A) |
Recombinant murine MEC (CCL28)
|
5ug |
|
|
PeproTech |
130-01(A) |
Recombinant human MIA
|
5ug |
|
|
PeproTech |
130-02(A) |
Recombinant human MIA-2
|
5ug |
|
|
PeproTech |
450-16(A) |
Recombinant human Midkine
|
5ug |
|
|
PeproTech |
315-25(A) |
Recombinant murine Midkine
|
5ug |
|
|
PeproTech |
300-69(A) |
Recombinant human MIF
|
5ug |
|
|
PeproTech |
300-26(A) |
Recombinant human MIG (CXCL9)
|
5ug |
|
|
PeproTech |
250-18(A) |
Recombinant murine MIG (CXCL9)
|
5ug |
|
|
PeproTech |
300-08(A) |
Recombinant human MIP-1α (CCL3)
|
5ug |
|
|
PeproTech |
250-09(A) |
Recombinant murine MIP-1α (CCL3)
|
2ug |
|
|
PeproTech |
400-15(A) |
Recombinant rat MIP-1α (CCL3)
|
5ug |
|
|
PeproTech |
130-12(A) |
Recombinant human Maspin
|
5ug |
|
|
PeproTech |
300-25(A) |
Recombinant human M-CSF
|
2ug |
|
|
PeproTech |
315-02(A) |
Recombinant murine M-CSF
|
2ug |
|
|
PeproTech |
400-28(A) |
Recombinant rat M-CSF
|
2ug |
|
|
PeproTech |
300-04(A) |
Recombinant human MCP-1/MCAF (CCL2)
|
5ug |
|
|
PeproTech |
400-12(A) |
Recombinant rat MCP-1 (CCL2)
|
2ug |
|
|
PeproTech |
300-15(A) |
Recombinant human MCP-2 (CCL8)
|
2ug |
|
|
PeproTech |
250-14(A) |
Recombinant murine MCP-2 (CCL8)
|
5ug |
|
|
PeproTech |
300-17(A) |
Recombinant human MCP-3 (CCL7)
|
2ug |
|
|
PeproTech |
250-08(A) |
Recombinant murine MCP-3 (CCL7)
|
2ug |
|
|
PeproTech |
300-24(A) |
Recombinant human MCP-4 (CCL13)
|
5ug |
|
|
PeproTech |
250-04(A) |
Recombinant murine MCP-5 (CCL12)
|
5ug |
|
|
PeproTech |
300-36(A) |
Recombinant human MDC (67 a.a.)(CCL22)
|
5ug |
|
|
PeproTech |
300-36A(A) |
Recombinant human MDC (69 a.a.)(CCL22)
|
5ug |
|
|
PeproTech |
250-36(A) |
Recombinant murine LIX/CXCL6 (70 a.a.)
|
5ug |
|
|
PeproTech |
250-17(A) |
Recombinant murine LIX/CXCL6 (93 a.a.)
|
5ug |
|
|
PeproTech |
250-37(A) |
Recombinant murine Lungkine (CXCL15)
|
5ug |
|
|
PeproTech |
300-20(A) |
Recombinant human Lymphotactin (XCL1)
|
5ug |
|
|
PeproTech |
450-54(A) |
Recombinant Lysobacter Enzymogenes Arg-C
|
5ug |
|
|
PeproTech |
450-06(A) |
Recombinant human MANF
|
5ug |
|
|
PeproTech |
100-19(A) |
Recombinant human KGF/FGF-7
|
2ug |
|
|
PeproTech |
110-08(A) |
Recombinant human KLF4-TAT
|
5ug |
|
|
PeproTech |
100-53(A) |
Recombinant human Klotho
|
5ug |
|
|
PeproTech |
300-58(A) |
Recombinant human LAG-1 (CCL4L1)
|
5ug |
|
|
PeproTech |
300-56(A) |
Recombinant human LD78β (CCL3L1)
|
5ug |
|
|
PeproTech |
300-44(A) |
Recombinant human LEC/NCC-4 (CCL16)
|
5ug |
|
|
PeproTech |
300-27(A) |
Recombinant human Leptin
|
200ug |
|
|
PeproTech |
450-31(A) |
Recombinant murine Leptin
|
200ug |
|
|
PeproTech |
300-05(A) |
Recombinant human LIF
|
5ug |
|
|
PeproTech |
250-02(A) |
Recombinant murine LIF
|
5ug |
|
|
PeproTech |
400-21(A) |
Recombinant rat Leptin
|
200ug |
|
|
PeproTech |
310-09B(A) |
Recombinant human LIGHT
|
3ug |
|
|
PeproTech |
315-12(A) |
Recombinant murine LIGHT
|
5ug |
|
|
PeproTech |
110-06(A) |
Recombinant human Lin28-TAT
|
5ug |
|
|
PeproTech |
400-33(A) |
Recombinant rat IP-10 (CXCL10)
|
5ug |
|
|
PeproTech |
300-46(A) |
Recombinant human I-TAC (CXCL11)
|
5ug |
|
|
PeproTech |
250-29(A) |
Recombinant murine I-TAC (CXCL11)
|
5ug |
|
|